OpenInsiders01Web Canada
SEC INSIDER TRANSACTIONS

QUEST DIAGNOSTICS INC (DGX) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

DGX · QUEST DIAGNOSTICS INC

How to read this data ↗
More transaction filters

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters
Stale snapshot · Covered: filings 2026-10-15 to 2026-11-13 · 14 filings · fetched 2026-11-13T17:19:48Z

View six-calendar-month insider history →

Recent reported activity

0purchase rows on this page
0sale rows on this page
29matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filedReporting owner(s)Code / securityQuantityPrice as filedOwnershipSource
2026-10-21Filed 2026-10-23KUPPUSAMY KARTHIKOfficer · SVP, Clinical Solutions
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

F2 The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

F3 These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.

References: F1, F2

L Other reported codeCommon Stock · Non-derivative33A235.944DirectForm 4 ↗0001022079-26-000113
2026-10-21Filed 2026-10-23Gregg Vicky BDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

References: F1

A Award / grantCommon Stock · Non-derivative63A235.939DirectForm 4 ↗0001022079-26-000114
2026-10-21Filed 2026-10-23SAMAD SAMOfficer · Executive Vice President & CFO
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

References: F1

A Award / grantCommon Stock · Non-derivative90A235.939DirectForm 4 ↗0001022079-26-000115
2026-10-21Filed 2026-10-23CARTER ROBERT BDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

References: F1

L Other reported codeCommon Stock · Non-derivative10A235.93DirectForm 4 ↗0001022079-26-000116

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.